Key Principles in Safely Prescribing Bispecific Antibodies in Heavily Pretreated Patients With Multiple Myeloma

Jun 8, 2023 3:00pm ‐ Jun 8, 2023 3:30pm

Identification: webccs230608

Speaker(s):


To Extend or Not Extend? Evaluating the Need for Extended Endocrine Therapy in Patients With Early-Stage HR+ Breast Cancer

Jun 27, 2023 3:00pm ‐ Jun 27, 2023 4:30pm

Identification: webccs230627

Speaker(s):


Management of Patients With Multiple Myeloma Receiving CAR T-Cell Therapy: Timing, Adverse Events, and Coordination of Care

Jul 20, 2023 3:00pm ‐ Jul 20, 2023 3:30pm

Identification: webccs230720

Speaker(s):


Managing Fertility and Treatment-related Side Effects in Premenopausal Patients with Breast Cancer

Sep 7, 2023 3:00pm ‐ Sep 7, 2023 4:00pm

Identification: webccs230907

Speaker(s):


Maintaining High Quality of Life, Good Performance Status in Refractory Colorectal Cancer

Oct 10, 2023 3:00pm ‐ Oct 10, 2023 3:30pm

Identification: webccs231010

Speaker(s):


Bispecific Antibodies in DLBCL: Navigating the Evolving Treatment Landscape

Oct 26, 2023 12:00pm ‐ Oct 26, 2023 12:30pm

Identification: webccs231026

Speaker(s):


Cytopenias, Including Transfusion-Dependent Anemia, in Myelofibrosis

Nov 1, 2023 4:00pm ‐ Nov 1, 2023 5:00pm

Identification: webccs231101

Speaker(s):